share_log

Wix.com Gears Up For Q1 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Wix.com Gears Up For Q1 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Wix.com爲第一季度的印刷做準備;這些最準確的分析師在業績電話會議之前修改了預測
Benzinga ·  05/17 22:35

Wix.com Ltd. (NASDAQ:WIX) is set to release earnings results for its first quarter, before the opening bell on Monday.

Wix.com有限公司(納斯達克股票代碼:WIX)將在週一開盤前公佈其第一季度的收益業績。

Analysts expect the Tel Aviv, Israel-based company to report quarterly earnings at $1.03 per share, up from 91 cents per share in the year-ago period. Wix.com is expected to post revenue of $417.84 million, according to data from Benzinga Pro.

分析師預計,這家總部位於以色列特拉維夫的公司將公佈的季度收益爲每股1.03美元,高於去年同期的每股91美分。根據Benzinga Pro的數據,Wix.com預計將實現4.1784億美元的收入。

Wix.com recently announced the launch of the AI Portfolio Creator, which enhances how users create and showcase an online professional portfolio.

Wix.com最近宣佈推出AI Portfolio Creator,它增強了用戶創建和展示在線專業作品集的方式。

Wix.com shares slipped 1.6% to close at $135.21 on Thursday.

週四,Wix.com股價下跌1.6%,收於135.21美元。

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Benzinga的讀者可以在分析師股票評級頁面上訪問最新的分析師評級。讀者可以按股票行情、公司名稱、分析公司、評級變化或其他變量進行排序。

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

讓我們來看看Benzinga最準確的分析師在最近一段時間對該公司的評級。

  • Benchmark analyst Mark Zgutowicz reiterated a Buy rating with a price target of $175 on May 15. This analyst has an accuracy rate of 66%.
  • JMP Securities analyst Andrew Boone reiterated a Market Outperform rating with a price target of $150 on April 30. This analyst has an accuracy rate of 73%.
  • Raymond James analyst Josh Beck reinstated an Outperform rating with a price target of $160 on March 27. This analyst has an accuracy rate of 74%.
  • RBC Capital analyst Brad Erickson maintained an Outperform rating and boosted the price target from $135 to $160 on Feb. 22. This analyst has an accuracy rate of 69%.
  • Piper Sandler analyst Clarke Jeffries maintained an Overweight rating and increased the price target from $146 to $165 on Feb. 22. This analyst has an accuracy rate of 61%.
  • 基準分析師馬克·茲古托維奇在5月15日重申了買入評級,目標股價爲175美元。這位分析師的準確率爲66%。
  • JMP證券分析師安德魯·布恩在4月30日重申了市場跑贏大盤的評級,目標股價爲150美元。這位分析師的準確率爲73%。
  • 雷蒙德·詹姆斯分析師喬什·貝克於3月27日恢復了跑贏大盤的評級,目標股價爲160美元。這位分析師的準確率爲74%。
  • 加拿大皇家銀行資本分析師布拉德·埃裏克森維持跑贏大盤的評級,並於2月22日將目標股價從135美元上調至160美元。該分析師的準確率爲69%。
  • 派珀·桑德勒分析師克拉克·傑弗里斯維持增持評級,並於2月22日將目標股價從146美元上調至165美元。該分析師的準確率爲61%。

Read This Next: Over $1M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying

接下來閱讀這篇文章:押注超過100萬美元的醫療保健股票?看看內部人士正在買入的這3只股票

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論